ArticleDrug design, development and therapy2026
Identification of Antibacterial Hits Associated with Penicillin-Binding Protein 2 in
Article in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Early-stage antibacterial candidate selection requires balancing antibacterial activity with broader developability-related properties. This study developed and applied a Fivefold Maximum Drug-Likeness strategy (5F-MDL) for prioritizing antibacterial candidates against Methods: An ensemble of deep learning models generated a 33-dimensional property spectrum covering physicochemical, pharmacokinetic, efficacy-related, safety, and stability endpoints. Approximately 16 million commercial molecules were screened, and fifteen candidates were experimentally evaluated by disk diffusion and broth microdilution. Molecular docking, molecular dynamics simulations, and a Bocillin-FL competition assay examined potential PBP2-associated interactions. Results: The fifteen prioritized candidates showed high property-spectrum similarity to reference antibiotics, with [Formula: see text] scores ranging from 0.929 to 0.971. Broth microdilution identified several molecules with measurable antibacterial activity, among which M2 showed the most balanced overall profile, including an MIC of 25.6 µg/mL and the largest inhibition zone among the candidates. Docking in the 549 Å Conclusion: The 5F-MDL workflow provides a multidimensional property-spectrum-based approach for early-stage antibacterial candidate prioritization. M2 was identified as a preliminary lead-like hit, although its mechanism, safety profile, and broader applicability require further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.